Gold nanoparticles and lipoic acid as a novel anti-inflammatory treatment for autism, a hypothesis

Journal of Medical Hypotheses and Ideas

Volumn 6, Issue 1, 2012, Pages 40-43

  Ghanizadeh, Ahmad ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autism; Gold; Inflammation; Lipoic acid; Oxidative stress; Treatment

Indexed keywords

ANTIINFLAMMATORY AGENT; CATALASE; GLUTATHIONE PEROXIDASE; GOLD NANOPARTICLE; PLACEBO; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUTISM; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EVIDENCE BASED MEDICINE; NERVOUS SYSTEM INFLAMMATION; NEURITIS; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; TREATMENT RESPONSE; VALIDATION STUDY;

EID: 84872025177     PISSN: 22517294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhi.2012.03.004     Document Type: Article

References (34)

1. Leu JG, Chen SA, Chen HM, Wu WM, Hung CF, Yao YD, et al. The effects of gold nanoparticle in wound healing with anti-oxidant epigallocatechin gallate and alpha lipoic acid. Nanomedicine 2011 [first online] Sep 9.
2. Ghanizadeh A. Gold implants and increased expression of metallothionein-I/II as a novel hypothesized therapeutic approach for autism. Toxicology 2011;283:63-4.
3. Ghanizadeh A. Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism. Expert Opin Ther Targets 2011;15:781-3.
4. Ghanizadeh A. Targeting mitochondria by olesoxime or complement 1q binding protein as a novel management for autism: a hypothesis. Mol Syndromol 2011;2:50-2.
5. Ghanizadeh A. A novel hypothesized clinical implication of zonisamide for autism. Ann Neurol 2011;69(2):426.
6. Ghanizadeh A. Can ziconotide as a N-type voltage-sensitive calcium channel blocker open a new mode for treatment of autism? A hypothesis. Neurosciences (Riyadh) 2011;16:83.
7. Ghanizadeh A. C-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication. J Autism Dev Disord 2011;41:1591-2.
8. Ghanizadeh A. Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochem Res 2011;36:922-3.
9. Packer L, Cadenas E. Lipoic acid: energy metabolism and redox regulation of the transcription and cell signaling. J Clin Biochem Nutr 2011;48:26-32.
10. Salinthone S, Yadav V, Bourdette DN, Carr DW. Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr Metab Immune Disord Drug Targets 2008;8:132-42.
11. Chaudhary P, Marracci G, Yu X, Galipeau D, Morris B, Bourdette D. Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis. J Neuroimmunol 2011;233:90-6.
12. dos Santos PS, Feitosa CM, Saldanha GB, Tome Ada R, Feng D, de Freitas RM. Lipoic acid inhibits caspase-dependent and -independent cell death pathways and is neuroprotective against hippocampal damage after pilocarpine-induced seizures. Pharmacol Biochem Behav 2011;97:531-6.
13. de Freitas RM. Lipoic acid alters delta-aminolevulinic dehydratase, glutathione peroxidase and Na+, K+-ATPase activities and glutathione-reduced levels in rat hippocampus after pilocarpine-induced seizures. Cell Mol Neurobiol 2010;30:381-7.
14. Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, et al. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease. Adv Drug Deliv Rev 2008;60:1463-70.
15. Toklu HZ, Hakan T, Biber N, Solakoglu S, Ogunc AV, Sener G. The protective effect of alpha lipoic acid against traumatic brain injury in rats. Free Radic Res 2009;43:658-67.
16. Ying Z, Kampfrath T, Sun Q, Parthasarathy S, Rajagopalan S. Evidence that alpha-lipoic acid inhibits NF-kappaB activation independent of its antioxidant function. Inflamm Res 2011;60:219-25.
17. Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLoS One 2011;5(9):e13058.
18. Freitas RM. The evaluation of effects of lipoic acid on the lipid peroxidation, nitrite formation and antioxidant enzymes in the hippocampus of rats after pilocarpine-induced seizures. Neurosci Lett 2009;455:140-4.
19. Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, Münch G. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007;113:154-64.
20. Palmieri L, Persico AM. Mitochondrial dysfunction in autism spectrum disorders: cause or effect? Biochim Biophys Acta 2011;1797:1130-7.
21. Villagonzalo KA, Dodd S, Dean O, Gray K, Tonge B, Berk M. Oxidative pathways as a drug target for the treatment of autism. Expert Opin Ther Targets 2010;14:1301-10.
22. Ghanizadeh A. Oxidative stress may mediate association of stereotypy and immunity in autism, a novel explanation with clinical and research implications. J Neuroimmunol 2011;232:194-5.
23. Meguid NA, Dardir AA, Abdel-Raouf ER, Hashish A. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res 2011;143:58-65.
24. Mostafa GA, El-Hadidi ES, Hewedi DH, Abdou MM. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol 2010;219:114-8.
25. Krajcovicova-Kudlackova M, Valachovicova M, Mislanova C, Hudecova Z, Sustrova M, Ostatnikova D. Plasma concentrations of selected antioxidants in autistic children and adolescents. Bratisl Lek Listy 2009;110:247-50.
26. Al-Mosalem OA, El-Ansary A, Attas O, Al-Ayadhi L. Metabolic biomarkers related to energy metabolism in Saudi autistic children. Clin Biochem 2009;42:949-57.
27. Malik M, Sheikh AM, Wen G, Spivack W, Brown WT, Li X. Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects. Immunobiology 2011;216:80-5.
28. Sheikh AM, Malik M, Wen G, Chauhan A, Chauhan V, Gong CX, et al. BDNF-Akt-Bcl2 antiapoptotic signaling pathway is compromised in the brain of autistic subjects. J Neurosci Res 2011;88:2641-7.
29. Sheikh AM, Li X, Wen G, Tauqeer Z, Brown WT, Malik M. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 2010;165:363-70.
30. Ghanizadeh A. Methionine sulfoximine may improve inflammation in autism, a novel hypothesized treatment for autism. Arch Med Res 2010;41:651-2.
31. Ghanizadeh A. Targeting neurotensin as a potential novel approach for the treatment of autism. J Neuroinflammation 2010;7:58.
32. El-Ansary A, Al-Daihan S, Al-Dbass A, Al-Ayadhi L. Measurement of selected ions related to oxidative stress and energy metabolism in Saudi autistic children. Clin Biochem 2010;43:63-70.
33. Ghanizadeh A. Malondialdehyde, Bcl-2, superoxide dismutase and glutathione peroxidase may mediate the association of sonic hedgehog protein and oxidative stress in autism. Neurochem Res 2012;37:899-901.
34. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 2001;11:173-86.